Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.96 - $3.09 $127,400 - $200,850
-65,000 Reduced 76.02%
20,500 $42,000
Q1 2022

May 10, 2022

SELL
$2.3 - $3.61 $18,400 - $28,880
-8,000 Reduced 8.56%
85,500 $234,000
Q4 2021

Feb 09, 2022

BUY
$3.09 - $4.81 $3,090 - $4,810
1,000 Added 1.08%
93,500 $307,000
Q3 2021

Nov 08, 2021

BUY
$3.17 - $4.39 $9,510 - $13,169
3,000 Added 3.35%
92,500 $358,000
Q2 2021

Aug 11, 2021

BUY
$3.02 - $5.21 $270,290 - $466,295
89,500 New
89,500 $346,000

Others Institutions Holding IMMP

About IMMUTEP Ltd


  • Ticker IMMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,000
  • Market Cap $172M
  • Description
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...
More about IMMP
Track This Portfolio

Track Saturna Capital Corp Portfolio

Follow Saturna Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.